TRELEGY ELLIPTA
TRELEGY ELLIPTA
Approved
DIN Number
02515776
Drug Class
Human
Market Date
Sep 13, 2021
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02515776
AIG Number0360150002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03AL08 VILANTEROL, UMECLIDINIUM BROMIDE AND FLUTICASONE FUROATE
Product Specifications
Dosage FormPowder
Route of AdministrationInhalation
AHFS Classification12:12.08.12
Health Canada Classification
ACTIVE INGREDIENTS (3)
FLUTICASONE FUROATEActive
Strength: 200 MCG / ACT
Monograph: FLUTICASONE FUROATE
UMECLIDINIUM (UMECLIDINIUM BROMIDE)Active
Strength: 62.5 MCG / ACT
Monograph: UMECLIDINIUM (UMECLIDINIUM BROMIDE)
VILANTEROL (VILANTEROL TRIFENATATE)Active
Strength: 25 MCG / ACT
Monograph: VILANTEROL (VILANTEROL TRIFENATATE)